California Biotech Partners for Manufacture of COVID-19 Vaccine Candidate
Source: Streetwise Reports  (5/6/20)
Arcturus Therapeutics Holdings' arrangement is explained and commented on in an H.C. Wainwright & Co. report. More >

Biotech Develops Antagonists for Protein Tied to Neurodegenerative Diseases
Source: Streetwise Reports  (5/6/20)
ProMIS Neurosciences' antagonists prevent dysfunctional protein aggregation. More >

Horizon Therapeutics Shares Rise 15% on Strong Q1 Results and Raised F/Y Sales Guidance
Source: Streetwise Reports  (5/6/20)
Shares of Horizon Therapeutics traded higher setting a new 52-week high price after the company reported a 27% y-o-y increase in net sales for Q1/20 and raised FY/20 net sales guidance. More >

Firm Partners with Canada's Largest Western Grocery Chain and Leading Community Pharmacy to Pilot In-Store Virtual Patient Care
Source: Streetwise Reports  (5/5/20)
CloudMD announced that it is partnering with Save-On-Foods grocery stores and Pure Integrative Pharmacy to pilot on demand, integrated virtual patient care through telemedicine kiosks placed in pharmacies' existing consult rooms. More >

Alexion's Buyout of Portola Pharmaceuticals Gets Investors' Blood Flowing
Source: Streetwise Reports  (5/5/20)
Shares of Portola Pharmaceuticals traded 130% higher after the company reported that it has received an $18 per share buyout offer from Alexion Pharmaceuticals. More >

Telehealth Platform Added to Vendor Lists of Leading Medical Associations
Source: Streetwise Reports  (5/4/20)
Use of CloudMD Software & Services' health solution is seeing significant growth. More >

Firm Creates Novel Intrabodies for ALS and Other Neurodegenerative Diseases
Source: Streetwise Reports  (5/4/20)
ProMIS Neurosciences reported it has generated novel intrabodies that are highly selective for misfolded forms of TAR DNA-binding protein 43 implicated in several neurologic disorders. More >

Stemline Shares Take Off on $677 Million Buyout Offer by Global Pharmaceutical Firm
Source: Streetwise Reports  (5/4/20)
Shares of Stemline Therapeutics traded 150% higher after the company reported that it has entered into a definitive agreement to be acquired by Italy's Menarini Group in a deal valued at up to $677 million. More >

Seattle Genetics Shares Trade Higher on Q1/20 Earnings and 22% Growth in ADCETRIS Sales
Source: Streetwise Reports  (5/1/20)
Seattle Genetics shares traded 8% higher, reaching a new 52-week high, after the company reported Q1/20 financial results which included a 10% y-o-y increase in net revenues fueled by a 22% increase in sales of ADCETRIS® and a strong debut for PADCEVâ„¢ in its first full quarter of sales. More >

Biotech Cleared for Phase 2b/3 Trial of NMDA Receptor Antagonist for COVID-19 Patients in Canada
Source: Streetwise Reports  (4/30/20)
Algernon Pharmaceuticals reported it received approval from Health Canada for a Phase 2b/3 multinational clinical study of Ifenprodil in COVID-19 patients to prevent progression to intubation and mechanical ventilation. More >

Mobile Health Solutions Firm Welcomes 8 New Texas Clients to Its Telemedicine Platform
Source: Streetwise Reports  (4/30/20)
Reliq Health Technologies reported that it has signed contracts to add eight new customers in Texas including an oncology practice that will be using its new iUGO Care Principal Care Management module. More >

US Counties to Use Tech Firm's Software for COVID-19 Contact Tracing
Source: Streetwise Reports  (4/29/20)
Demand has been taking off for HealthSpace Data Systems' platform released two weeks ago. More >

Chimerix Shares Rise 50% as FDA Gives 'Go Ahead' for Phase 2/3 ALI Study in COVID-19 Patients
Source: Streetwise Reports  (4/29/20)
Shares of Chimerix Inc. traded higher after the company reported it has received U.S. FDA clearance to initiate a Phase 2/3 Study of dociparstat sodium in acute lung injury for patients afflicted with severe COVID-19. More >

With Contact Tracing Key to Reopening the Economy, New Cloud Platform Attracting High-Profile Users
Source: Streetwise Reports  (4/28/20)
As contact tracing moves to center stage as a key to reopening the economy, HealthSpace releases a scalable cloud-based system that is rapidly being adopted, including by the state of Hawaii. More >

Why These 2 Investment Professionals Say This Telemedicine Company Is One of Their Top Picks
Source: Streetwise Reports  (4/28/20)
As the coronavirus pandemic has accelerated the move to telemedicine, two investment professionals are following CloudMD, a small cap rapidly expanding in Canada. More >

CloudMD Is My TeleHealth Stock
Source: Keith Schaefer for Streetwise Reports  (4/28/20)
With telehealth becoming a rising star in the coronavirus era, Keith Schaefer discusses why one company rapidly expanding in Canada stands out. More >

SmileDirectClub Awarded US Patent for SmileShop Concept and Plans to Reopen Stores in May
Source: Streetwise Reports  (4/28/20)
SmileDirectClub shares traded 20% higher after the company reported it has been awarded a U.S. patent for its SmileShop retail concept and treatment process and that it plans to reopen stores on a rolling basis starting in May. More >

Avadel Shares Rise and Shine on Positive Phase 3 Narcolepsy Study Findings
Source: Streetwise Reports  (4/27/20)
Avadel Pharmaceuticals' shares traded 25% higher reaching a new 52-week high price after the company reported positive topline results from its Pivotal Phase 3 REST-ON trial of FT218 for the treatment of excessive daytime sleepiness and cataplexy in narcolepsy patients. More >

Mesoblast Shares Soar 120% After Reporting 83% Survival Rate in COVID-19 Patients with ARDS
Source: Streetwise Reports  (4/24/20)
Shares of Mesoblast more than doubled and set a new 52-week high price after the company reported that it achieved a 83% survival rate in New York ventilator-dependent COVID-19 patients with moderate to severe acute respiratory distress syndrome who were treated with its allogeneic cell therapy remestemcel-L. More >

West Pharma Services' Shares Rise 10% on Q1 Sales Growth and Raised FY Earnings Guidance
Source: Streetwise Reports  (4/23/20)
Shares of West Pharmaceutical Services traded higher and established a new 52-week high price after the firm reported Q1/20 earnings that included a 10.8% increase in YoY revenues. More >

Biopharma Approved to Launch COVID-19 Trial in South Korea
Source: Streetwise Reports  (4/23/20)
Algernon Pharmaceuticals will evaluate one of its drugs in coronavirus-infected patients with severe pneumonia. More >

BARDA Award Provides 'Lift-off for Biotech's COVID Vaccine'
Source: Streetwise Reports  (4/22/20)
The ways in which Moderna is to use the funds are explained and an update on its coronavirus vaccine is provided in a ROTH Capital Partners report. More >

Biopharma Reports Consistent 'Phase 2 Liver Fat (NASH and NAFLD) Results'
Source: Streetwise Reports  (4/22/20)
The new data are reviewed and updates are provided on Can-Fite BioPharma's other clinical studies, including one for COVID-19, in this Dawson James research report. More >

Exelixis Shares Climb 21% on Positive Phase 3 Advanced Kidney Cancer Study Results
Source: Streetwise Reports  (4/20/20)
Shares of Exelixis reached a new 52-week high price after the firm reported positive topline results from its Pivotal Phase 3 CheckMate -9ER trial evaluating Opdivo® (nivolumab) in combination with CABOMETYX® (cabozantinib) in previously untreated advanced renal cell carcinoma. More >

Biotech to Test Stem Cell Product in COVID-19-Caused Acute Respiratory Distress
Source: Streetwise Reports  (4/15/20)
A description of Mesoblast's multi-site clinical trial and possible implication for the therapeutic are provided in an H.C. Wainwright & Co. report. More >